SmithKline Beecham fined in HungaryBMJ 1997; 315 doi: https://doi.org/10.1136/bmj.315.7120.1397l (Published 29 November 1997) Cite this as: BMJ 1997;315:1397
- Carl Kovac
SmithKline Beecham Pharmaceuticals has been fined one million Hungarian florints (£3065) by the Hungarian Consumer Protection Authority and ordered to withdraw advertisements that promote vaccinations against hepatitis B.
The advertisements started appearing in August in magazines targeted at teenagers and on television. According to the national public health commissioner, Ilona Molnár, the advertisements exaggerated the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial